However, inactivation of MMR genes like MSH3 and MSH5 by methylation and single nucleotide polymorphisms (SNPs) has been associated with increased sensitivity to cisplatin-based chemotherapy in small cell lung carcinoma (J.-Y. The gene discussed is MRC1; the disease is small cell lung carcinoma.